Torrent Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹2,452 Crore, up from ₹ Crore year on year depicting a growth of 17%. Consolidated Net Profit of ₹287 Crore, up 343% from -(₹118) Crore in the same quarter of the previous year. The Earnings per Share is ₹8.48, up 343% from -(₹3.49) in the same quarter of the previous year.
Torrent Pharmaceuticals Ltd Q4FY23 revenue grows by 17%
Related Post
- Sula Vineyards Limited posts lower Q3 FY26 profit as tactical destocking hits margins; wine tourism revenue rises
Sula Vineyards Limited (NSE: SULA, BSE: 543711) reported lower profit for the quarter ended Dec.…
-
Filatex India Limited posts stable Q3 FY26 revenue as margins improve on product mix and efficiency gains
Filatex India Limited (NSE: FILATEX, BSE: 526227) reported stable revenue and improved profitability for the…
-
Man Industries (India) Limited reports strong Q3 FY26 earnings as margins expand and order book rises
Man Industries (India) Limited (NSE: MANINDS, BSE: 513269) reported a sharp increase in revenue, profit…